CareMax Inc. (CMAX) Financial Statements (2026 and earlier)

Company Profile

Business Address 1000 NW 57TH COURT, SUITE 400
MIAMI, FL 33126
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 805 - Nursing And Personal Care Facilities (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments41,47965,52832,26454,60544,22241,626
Cash and cash equivalent41,47965,52832,26454,60544,22241,626
Receivables107,985114,754139,573159,812158,989151,036
Inventory, net of allowances, customer advances and progress billings      723
Inventory      723
Other current assets6,6503,0663,8203,5165,9283,245
Other undisclosed current assets(1) 1,005717859706
Total current assets:156,113183,348176,662218,650209,998197,336
Noncurrent Assets
Operating lease, right-of-use asset109,947109,215130,826131,207115,018108,937
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization47,24347,91827,83724,62822,72621,006
Intangible asset, including goodwill, after accumulated amortization252,933258,084629,532715,180720,832824,228
Goodwill156,841156,841522,643602,643602,643700,643
Intangible asset, excluding goodwill, after accumulated amortization96,092101,243106,889112,537118,189123,585
Deferred costs   8961,0521,8421,685
Other noncurrent assets47,96524,73792,36360,24927,28617,550
Other undisclosed noncurrent assets 1(1)1(1)(1)1
Total noncurrent assets:458,089439,953881,455932,315887,703973,407
TOTAL ASSETS:614,202623,3011,058,1171,150,9651,097,7011,170,743
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26,87622,49924,34421,31126,73626,318
Accounts payable6,7046,2759,3458,6778,1347,687
Accrued liabilities20,17216,22414,99912,63418,60218,631
Debt410,763364,38034,87233,273  
Other liabilities2,3541658,5897,3034,103790
Due to related parties13,41031,54830,277
Other undisclosed current liabilities67,12151,76830,53622,77218,04119,937
Total current liabilities:507,114438,81298,34198,06980,42877,322
Noncurrent Liabilities
Long-term debt and lease obligation1,87921,443302,612298,481260,642230,725
Long-term debt, excluding current maturities1,87921,443302,612298,481260,642230,725
Liabilities, other than long-term debt84,806101,579131,565127,484115,574104,614
Other liabilities6,3404,44313,89711,2979,2838,075
Operating lease, liability78,41797,136117,668116,187106,29196,539
Derivative instruments and hedges, liabilities49     
Other undisclosed noncurrent liabilities 1229832,435101,294138,535
Total noncurrent liabilities:86,686123,044435,160428,400477,510473,874
Total liabilities:593,800561,856533,501526,469557,938551,196
Equity
Equity, attributable to parent, including:20,40361,444524,616624,496539,763619,547
Common stock111111111111
Additional paid in capital784,736782,371779,776776,533659,424657,126
Accumulated deficit(764,345)(720,938)(255,171)(152,048)(119,672)(37,590)
Other undisclosed equity, attributable to parent 1     
Other undisclosed equity(1)1    
Total equity:20,40261,445524,616624,496539,763619,547
TOTAL LIABILITIES AND EQUITY:614,202623,3011,058,1171,150,9651,097,7011,170,743

Income Statement (P&L) ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Revenues(540)(18,274)201,843224,44026,900164,263
Gross profit:(540)(18,274)201,843224,44026,900164,263
Operating expenses(253,951)(604,842)(292,615)(228,191)(281,606)(250,498)
Other undisclosed operating income 232,786170,109 1146,083 
Operating loss:(21,705)(453,007)(90,772)(3,750)(108,623)(86,235)
Nonoperating income (expense)(21,526)(14,155)(12,174)(28,449)26,71822,314
Interest and debt expense     6,200 
Loss from continuing operations before equity method investments, income taxes:(43,231)(467,162)(102,946)(32,199)(75,705)(63,921)
Other undisclosed income (loss) from continuing operations before income taxes    (6,199)54,282
Loss from continuing operations before income taxes:(43,231)(467,162)(102,946)(32,199)(81,904)(9,639)
Income tax expense (benefit)(177)1,395(177)(177)(177)20,074
Income (loss) from continuing operations:(43,408)(465,767)(103,123)(32,376)(82,081)10,435
Other undisclosed net loss     (1)(1)
Net income (loss) available to common stockholders, diluted:(43,408)(465,767)(103,123)(32,376)(82,082)10,434

Comprehensive Income ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Net income (loss):(43,408)(465,767)(103,123)(32,376)(82,082)10,434
Comprehensive income (loss), net of tax, attributable to parent:(43,408)(465,767)(103,123)(32,376)(82,082)10,434

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: